1. Definition and Classification (ILAE 2017)

  • Current Terminology: Self-limited epilepsy with centrotemporal spikes (SeLECTS).
  • Definition: A common, genetic, age-dependent, self-limited focal epilepsy syndrome characterized by sensorimotor seizures affecting the face/oropharynx, typically occurring during sleep, with distinctive EEG patterns.
  • Epidemiology:
    • Most common childhood focal epilepsy (15–25% of childhood epilepsies).
    • Age of Onset: 3 to 13 years (Peak: 7–9 years).
    • Sex: Slight male predominance (1.5:1).
    • Course: Invariably resolves by adolescence (15–16 years).

2. Etiology and Genetics

  • Genetics: Complex inheritance pattern.
    • Centrotemporal spikes (CTS) on EEG follow an autosomal dominant inheritance with age-dependent penetrance.
    • Specific genes: ELP4 (11p13), GRIN2A (linked to speech disorders/epilepsy spectrum).
  • Pathophysiology: Cortical hyperexcitability in the lower Rolandic area (somatomotor cortex).

3. Clinical Features

A. Seizure Characteristics

  • Timing: 70–80% occur during sleep (NREM) or upon awakening.
  • Type: Focal motor/sensory seizures, often evolving to focal to bilateral tonic-clonic seizures (FBTCS).
  • The “Rolandic” Symptoms (Sylvian Seizures):
    • Unilateral facial sensorimotor symptoms: Paresthesia (numbness/tingling) of tongue, gum, cheek, or lips.
    • Oropharyngolaryngeal manifestations: Guttural sounds, death rattle-like noises.
    • Speech Arrest (Anarthria): Inability to speak despite preserved consciousness (due to motor aphonia, not aphasia).
    • Hypersalivation (Sialorrhea): Prominent pooling of saliva.
    • Clonic movements: Twitching of one side of the face, mouth, or pharynx.
  • Consciousness: Usually preserved in focal seizures; lost if secondary generalization occurs.
  • Frequency: Usually infrequent; 10–20% of patients have only a single seizure.

B. Neurological Examination

  • Normal neurological status.
  • Normal intelligence (though subtle neurocognitive deficits in language/attention may exist).

4. Investigations

A. Electroencephalogram (EEG) - Diagnostic Hallmark

  • Background: Normal.
  • Interictal Features:
    • Morphology: High voltage, blunt, diphasic spikes followed by a slow wave.
    • Location: Centrotemporal (C3, C4, T3, T4) or Rolandic area.
    • Field: Horizontal Dipole characteristic (positivity in frontal regions, negativity in centrotemporal regions).
    • Activation: Spikes significantly increase (by >30%) during NREM sleep.
    • Laterality: Can be unilateral, bilateral independent, or shifting side-to-side.

B. Neuroimaging (MRI Brain)

  • Indication: Not routinely required if clinical picture and EEG are classical.
  • Recommended if:
    • Onset <3 years or >12 years.
    • Abnormal neurological exam.
    • Drug resistance.
    • Atypical EEG features.
  • Finding: Usually normal.

5. Differential Diagnosis

  • Panayiotopoulos Syndrome: Autonomic seizures (vomiting), occipital spikes.
  • Benign Epilepsy with Occipital Paroxysms (Gastaut Type): Visual hallucinations.
  • Structural Focal Epilepsy: Tumor or cortical dysplasia (ruled out by MRI).
  • Landau-Kleffner Syndrome / CSWS: If significant language regression or continuous spike-waves in sleep occur.

6. Management

A. General Measures

  • Counseling parents regarding the benign nature and self-limiting course.
  • Sleep hygiene maintenance (sleep deprivation triggers seizures).

B. Decision to Treat

  • Observation (No medication): Preferred for:
    • First seizure.
    • Rare/infrequent seizures (e.g., <2 per year).
    • Nocturnal-only seizures causing minimal disruption.
  • Indication for AEDs:
    • Frequent seizures impacting life.
    • Daytime seizures (social stigma/risk).
    • Secondary generalization (GTCS).
    • Co-morbid cognitive/learning issues (controversial).

C. Pharmacotherapy

  • First Line:
    • Carbamazepine: 10–20 mg/kg/day. Highly effective.
    • Oxcarbazepine: Better tolerability profile.
    • Levetiracetam: Increasingly used due to low side effect profile.
  • Alternatives: Valproate (if overlap with generalized epilepsy), Sulthiame (common in Europe), Gabapentin.
  • Drugs to Avoid: Phenytoin, Phenobarbitone (cognitive side effects). Lamotrigine may rarely exacerbate myoclonus or spikes.

7. Complications and Atypical Evolution

  • “Atypical” Rolandic Epilepsy: Early onset, developmental delay, or atypical EEG.
  • ESES/CSWS Spectrum: Rare progression to Electrical Status Epilepticus in Sleep leading to cognitive/language regression.
  • Opercular Syndrome: Drooling, dysarthria, and facial diplegia due to frequent epileptic activity.

8. Prognosis

  • Seizures: Excellent. >95% remission by age 15–16.
  • Neurodevelopment: Generally normal outcome.
  • Relapse: Risk of adult epilepsy is very low (<2%).